| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chairman &CEO | Director
2 companies
Bentsur Ron serves as a Chairman &CEO at NVCT and has filed Form 4s across 2 companies. Across recent SEC filings that breaks down to 78 buys and 28 sells. Those positions are worth an estimated $83.6M at current prices.
Historically, Bentsur Ron's trades have earned a middling insider score of 64/100 across 73 rated trades. Over a 12-month horizon, 52.8% of those trades were profitable, with an average 12-month return of +6.6%.
The biggest single holding is NVCT (~$82.8M) as Chairman &CEO. Net of sales, the recent Form 4 record there shows accumulation of 392,965 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,000 | $7.35 | $7,345.00 | - | +4.7% | +81.8% | |
| Sep 26, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,500 | $7.85 | $11,775.00 | - | -4.8% | +77.8% | |
| Sep 2, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,700 | $8.29 | $14,099.00 | - | -8.4% | +78.5% | |
| Aug 29, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,500 | $9.05 | $13,570.00 | - | -16.6% | +70.9% | |
| Aug 19, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 19,426 | $8.69 | $168,725.08 | +0.3% | -19.9% | +66.1% | |
| Aug 11, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 19,669 | $8.40 | $165,219.60 | +0.7% | -17.3% | +79.3% | |
| Jun 30, 2022 | XAIR Beyond Air, Inc. | Director | Sell | 40,000 | $6.53 | $261,104.00 | -21.9% | +18.5% | -36.3% | |
| Jun 29, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 4,000 | $11.64 | $46,540.00 | - | -36.7% | +38.0% | |
| Jun 24, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 700 | $12.09 | $8,462.00 | - | -32.0% | +47.5% | |
| May 27, 2022 | NVCT Nuvectis Pharma, Inc. | Chairman &CEO | Buy | 1,000 | $15.82 | $15,820.00 | - | -45.7% | +12.1% |